Oral BCG vaccine in Crohn’s disease.
Gut. 1979 Mar;20(3):229-33
Authors: Burnham WR, Lennard-Jones JE, Hecketsweiler P, Colin R, Geffroy Y
In a randomised double-blind trial over one year oral BCG has been compared with a control preparation in the treatment of chronic Crohn’s disease. Overall assessment scores deteriorated in nine of 22 patients taking BCG, and 11 of 26 in the control group (P = 0.25); this deterioration was great enough to be regarded as a clinical relapse in three patients taking BCG and in seven taking the control preparation (P greater than 0.1). No significant benefit from oral BCG treatment has been demonstrated.
PMID: 374194 [PubMed – indexed for MEDLINE]